Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • FDA’s proposed rule and its re...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States

FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States

Show other versions (1)
Bibliographic Details
Main Authors: Alberto E. Paniz-Mondolfi, Juan David Ramírez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081280/?tool=EBI
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081280/?tool=EBI

Similar Items

  • FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States.
    by: Alberto E Paniz-Mondolfi, et al.
    Published: (2024-05-01)
  • The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
    by: Peter Marks
    Published: (2019-09-01)
  • The effects of lobbying on the FDA’s recall classification
    by: Yifan Zhou
    Published: (2023-06-01)
  • Restructuring the FDA’s Food Program: Promises and Pitfalls
    by: Sammer Marzouk, et al.
    Published: (2024-10-01)
  • New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science
    by: Kimberly Chiu, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs